339 related articles for article (PubMed ID: 29976521)
1. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin.
Whiley DM; Jennison A; Pearson J; Lahra MM
Lancet Infect Dis; 2018 Jul; 18(7):717-718. PubMed ID: 29976521
[No Abstract] [Full Text] [Related]
2. Multidrug-resistant
Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
[TBL] [Abstract][Full Text] [Related]
3. Detection in the United Kingdom of the
Eyre DW; Town K; Street T; Barker L; Sanderson N; Cole MJ; Mohammed H; Pitt R; Gobin M; Irish C; Gardiner D; Sedgwick J; Beck C; Saunders J; Turbitt D; Cook C; Phin N; Nathan B; Horner P; Fifer H
Euro Surveill; 2019 Mar; 24(10):. PubMed ID: 30862336
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant
Golparian D; Rose L; Lynam A; Mohamed A; Bercot B; Ohnishi M; Crowley B; Unemo M
Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482267
[TBL] [Abstract][Full Text] [Related]
5. Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant
Jennison AV; Whiley D; Lahra MM; Graham RM; Cole MJ; Hughes G; Fifer H; Andersson M; Edwards A; Eyre D
Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808445
[TBL] [Abstract][Full Text] [Related]
6. Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM
Emerg Infect Dis; 2017 Sep; 23(9):1478-1485. PubMed ID: 28820128
[TBL] [Abstract][Full Text] [Related]
7. High-level azithromycin-resistant Neisseria gonorrhoeae clinical isolate in France, March 2014.
Bercot B; Belkacem A; Goubard A; Mougari F; Sednaoui P; La Ruche G; Cambau E
Euro Surveill; 2014 Nov; 19(44):. PubMed ID: 25394255
[TBL] [Abstract][Full Text] [Related]
8. First Case of High-Level Azithromycin-Resistant Neisseria gonorrhoeae in North Carolina.
Palavecino EL; Kilic A; Schmerer MW; Dobre-Buonya O; Toler C; McNeil CJ
Sex Transm Dis; 2020 May; 47(5):326-328. PubMed ID: 32073548
[TBL] [Abstract][Full Text] [Related]
9. Extensively drug-resistant (XDR)
Pleininger S; Indra A; Golparian D; Heger F; Schindler S; Jacobsson S; Heidler S; Unemo M
Euro Surveill; 2022 Jun; 27(24):. PubMed ID: 35713023
[TBL] [Abstract][Full Text] [Related]
10. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
[TBL] [Abstract][Full Text] [Related]
11. Evidence for Clonally Associated Increasing Rates of Azithromycin Resistant
Barros Dos Santos KT; Skaf LB; Justo-da-Silva LH; Medeiros RC; Francisco Junior RDS; Caniné MCA; Fracalanzza SEL; Bonelli RR
Biomed Res Int; 2019; 2019():3180580. PubMed ID: 30800666
[TBL] [Abstract][Full Text] [Related]
12. CDC update on gonorrhea: expand treatment to limit resistance.
Campos-Outcalt D
J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356
[No Abstract] [Full Text] [Related]
13. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016.
Yin YP; Han Y; Dai XQ; Zheng HP; Chen SC; Zhu BY; Yong G; Zhong N; Hu LH; Cao WL; Zheng ZJ; Wang F; Zhi Q; Zhu XY; Chen XS
PLoS Med; 2018 Feb; 15(2):e1002499. PubMed ID: 29408881
[TBL] [Abstract][Full Text] [Related]
15. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
[TBL] [Abstract][Full Text] [Related]
16. Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
Zhao L; Liu A; Li R; Zhao S
Int J Antimicrob Agents; 2018 Jan; 51(1):52-56. PubMed ID: 28729124
[TBL] [Abstract][Full Text] [Related]
17. The 2018-19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group report on the diagnosis and treatment of gonorrhoea in Europe.
Clarke E; Patel C; Patel R; Unemo M;
Int J STD AIDS; 2020 Jan; 31(1):77-81. PubMed ID: 31793388
[No Abstract] [Full Text] [Related]
18. Australian gonococcal surveillance programme, 1 April to 30 June 2014.
Lahra MM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E390-2. PubMed ID: 25631604
[No Abstract] [Full Text] [Related]
19. Failure of azithromycin 2.0 g in the treatment of gonococcal urethritis caused by high-level resistance in California.
Gose SO; Soge OO; Beebe JL; Nguyen D; Stoltey JE; Bauer HM
Sex Transm Dis; 2015 May; 42(5):279-80. PubMed ID: 25868141
[TBL] [Abstract][Full Text] [Related]
20. Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
Lahra MM; Enriquez RP;
Commun Dis Intell Q Rep; 2015 Dec; 39(4):E628-30. PubMed ID: 26779739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
